BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22089097)

  • 1. Churg-Strauss syndrome: update on pathophysiology and treatment.
    Vaglio A; Moosig F; Zwerina J
    Curr Opin Rheumatol; 2012 Jan; 24(1):24-30. PubMed ID: 22089097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.
    Kim S; Marigowda G; Oren E; Israel E; Wechsler ME
    J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.
    Jakiela B; Sanak M; Szczeklik W; Sokolowska B; Plutecka H; Mastalerz L; Musial J; Szczeklik A
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S23-34. PubMed ID: 21470488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
    Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
    Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
    Hellmich B; Csernok E; Gross WL
    Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations and treatment of Churg-Strauss syndrome.
    Baldini C; Talarico R; Della Rossa A; Bombardieri S
    Rheum Dis Clin North Am; 2010 Aug; 36(3):527-43. PubMed ID: 20688248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art.
    Vaglio A; Buzio C; Zwerina J
    Allergy; 2013 Mar; 68(3):261-73. PubMed ID: 23330816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Churg-Strauss syndrome.
    Ramakrishna G; Midthun DE
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):603-13; quiz 13. PubMed ID: 11428732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
    Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
    Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Churg-Strauss syndrome: survival for 26 years.
    Vemuri P; Greenberger PA; Patterson R
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):640-3. PubMed ID: 12086374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Churg-Strauss syndrome: update on recent developments.
    Gross WL
    Curr Opin Rheumatol; 2002 Jan; 14(1):11-4. PubMed ID: 11790990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
    Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
    J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg-Strauss syndrome.
    Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():46-52. PubMed ID: 21646795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.
    Dallos T; Heiland GR; Strehl J; Karonitsch T; Gross WL; Moosig F; Holl-Ulrich C; Distler JH; Manger B; Schett G; Zwerina J
    Arthritis Rheum; 2010 Nov; 62(11):3496-503. PubMed ID: 20669282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Churg-Strauss syndrome.
    Pagnoux C; Guilpain P; Guillevin L
    Curr Opin Rheumatol; 2007 Jan; 19(1):25-32. PubMed ID: 17143092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.
    Saito H; Tsurikisawa N; Tsuburai T; Akiyama K
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():73-6. PubMed ID: 18504411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study.
    Zwerina J; Bach C; Martorana D; Jatzwauk M; Hegasy G; Moosig F; Bremer J; Wieczorek S; Moschen A; Tilg H; Neumann T; Spriewald BM; Schett G; Vaglio A
    Rheumatology (Oxford); 2011 Oct; 50(10):1823-7. PubMed ID: 21266446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the pathogenesis of Churg-Strauss syndrome.
    Hellmich B; Ehlers S; Csernok E; Gross WL
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S69-77. PubMed ID: 14740430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Churg-Strauss syndrome. Personal caseload and review of the literature].
    Manganelli P; Troise Rioda W; Buzio C; Pavesi G; Gemignani F
    Minerva Med; 1994; 85(7-8):387-93. PubMed ID: 7936357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome.
    Wieczorek S; Holle JU; Epplen JT
    Curr Opin Rheumatol; 2010 Jan; 22(1):8-14. PubMed ID: 19864953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.